Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v7-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-01-09 | 2019-01-04 |
| Drug Identification Number | 02230640 | 02230640 |
| Brand name | TOBRAMYCIN INJECTION | TOBRAMYCIN INJECTION |
| Common or Proper name | Tobramycin for Injection | Tobramycin for Injection |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | TOBRAMYCIN | TOBRAMYCIN |
| Strength(s) | 40MG | 40MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 2 mL | 2 mL |
| ATC code | J01GB | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-11-26 | 2018-11-26 |
| Actual start date | ||
| Estimated end date | ||
| Actual end date | 2019-01-08 | 2019-01-08 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of Tobramycin for Injection 40 mg/mL MD Vial 2 mL will be available at all distribution centers effective Tuesday, January 8, 2019 | Sandoz is an alternate supplier of Tobramycin for Injection 40 mg/mL 2 mL and has confirmed they are able to supply the market during our shortage. |
| Health Canada comments |